These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia]. Jiang Q, Chen SS, Jiang B, Jiang H, Lu Y, Qiu JY, Lu DP. Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504 [Abstract] [Full Text] [Related]
8. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome. Navarro JT, Feliu E, Grau J, Espinet B, Colomer D, Ribera JM, Oriol A, Granada I, Juncà J, Millá F. Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075 [Abstract] [Full Text] [Related]
15. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia. Kim M, Lee S, Jung CK, Lim J, Cho SG, Kim DW, Kim Y, Han K, Min WS, Kim CC. Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302 [Abstract] [Full Text] [Related]
16. [Disappearance of a Philadelphia chromosome-positive clone and appearance of a -negative clone following treatment with imatinib mesylate in acute myelomonocytic leukemia]. Takahashi W, Arai Y, Tadokoro J, Takeuchi K, Yamagata T, Mitani K. Rinsho Ketsueki; 2006 Feb; 47(2):111-4. PubMed ID: 16529013 [Abstract] [Full Text] [Related]